Lakefront Biotherapeutics NV (GXEA.F) Q3 2024 Earnings

1AugConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-1.97
-0.52
0.94
2.39

Details

Expected EPS
-0.06795157912883999
Actual EPS
0.10440008589912
Surprise EPS
0.17
Surprise Percent
+253.64%

Description

Lakefront Biotherapeutics NV (GXEA.F) has reported earnings of 0.10440008589912 per share for Q3 2024.

0 Comments

Share your thoughts